SCHEMBL20224057

SCHEMBL20224057

CC(=O)n1ccc2c(Cl)c(OC(C)(C)C)ccc21

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NOTUM Q6P988 3/20 0.63
▸ KDM4E B2RXH2 1/20 0.32
▸ ALDH1A1 P00352 1/20 0.32
▸ TP53 P04637 1/20 0.32
▸ HPGD P15428 1/20 0.32
▸ HSD17B10 Q99714 1/20 0.32
▸ CYP11B1 P15538 3/20 0.32
▸ CYP11B2 P19099 3/20 0.32
▸ PGR P06401 1/20 0.32
▸ AR P10275 1/20 0.32
▸ BRD4 O60885 1/20 0.31
▸ MEN1 O00255 1/20 0.31
▸ KMT2A Q03164 1/20 0.31
▸ NPC1 O15118 1/20 0.30
▸ JAK2 O60674 1/20 0.30
▸ MITF O75030 1/20 0.30
▸ RAB9A P51151 1/20 0.30
▸ PAX8 Q06710 1/20 0.30
▸ NPSR1 Q6W5P4 1/20 0.30
▸ NCOA3 Q9Y6Q9 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20224098 0.86 NOTUM (0.46) NOTUMALDH1A1HPGDHSD17B10PGR
SCHEMBL18052968 0.85 NOTUM (0.67) NOTUMKDM4EALDH1A1TP53HPGD
SCHEMBL20224065 0.84 NOTUM (0.50) NOTUMKDM4EALDH1A1TP53HPGD
SCHEMBL20224102 0.83 NOTUM (0.43) NOTUMKDM4EALDH1A1HPGDHSD17B10
SCHEMBL20224087 0.82 NOTUM (0.43) NOTUMALDH1A1HPGDPGRAR
SCHEMBL18054355 0.81 NOTUM (0.61) NOTUMKDM4EALDH1A1TP53HPGD
SCHEMBL20224081 0.80 NOTUM (0.41) NOTUMALDH1A1BRD4KMT2A
SCHEMBL17170046 0.76 RHEB (0.37) NOTUMKDM4EALDH1A1PGRAR
SCHEMBL20224066 0.74 POLB (0.36) NOTUMKDM4EHSD17B10KMT2ANPC1
SCHEMBL19645306 0.72 NOTUM (0.41) NOTUMBRD4MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10766879-B2 Pyrimidine derivatives as kinase inhibitors and their therapeutical applications NANTBIOSCIENCE, INC. (US) 2020-09-08 — — US disclosed
US-20180215734-A1 PYRIMIDINE DERIVATIVES AS KINASE INHIBITORS AND THEIR THERAPEUTICAL APPLICATIONS NANTBIOSCIENCE, INC. 2018-08-02 — — US disclosed
US-20180215734-A1 PYRIMIDINE DERIVATIVES AS KINASE INHIBITORS AND THEIR THERAPEUTICAL APPLICATIONS NANTBIOSCIENCE, INC. 2018-08-02 — — US disclosed
US-20180155327-A1 PYRIMIDINE DERIVATIVES AS KINASE INHIBITORS AND THEIR THERAPEUTICAL APPLICATIONS NANTBIOSCIENCE, INC. 2018-06-07 — — US disclosed
US-20180155327-A1 PYRIMIDINE DERIVATIVES AS KINASE INHIBITORS AND THEIR THERAPEUTICAL APPLICATIONS NANTBIOSCIENCE, INC. 2018-06-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180215734-A1 PYRIMIDINE DERIVATIVES AS KINASE INHIBITORS AND THEIR THERAPEUTICAL APPLICATIONS DCK, TK1, DTYMK NOTUM 4257/4885KDM4E 960/4885ALDH1A1 2203/4885
US-10766879-B2 Pyrimidine derivatives as kinase inhibitors and their therapeutical applications DCK, TK1, DTYMK NOTUM 4163/4885KDM4E 1226/4885ALDH1A1 2282/4885
US-20180155327-A1 PYRIMIDINE DERIVATIVES AS KINASE INHIBITORS AND THEIR THERAPEUTICAL APPLICATIONS DCK, TK1, DTYMK NOTUM 4163/4885KDM4E 1226/4885ALDH1A1 2282/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback